1 / 10

U.S. IVD Market Size, Share and Trends by 2023

U.S. IVD Market accounted for $15,746 million in 2016, and is estimated to reach at $20,707 million by 2023, growing at a CAGR of 3.9% from 2017 to 2023. In vitro diagnostics (IVD) are intended for in vitro analysis of samples derived from the human body, to provide information for diagnostic, monitoring, and treatment purposes.

Abhi711
Télécharger la présentation

U.S. IVD Market Size, Share and Trends by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. IVD Market Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Introductionof U.S. IVD Market The U.S. IVD market was valued at $15,746 million in 2016, and is projected to reach at $20,707 million by 2023, growing at a CAGR of 3.9% from 2017 to 2023. The reagent segment accounted for more than three-fifths share of the total market in 2016. In vitro diagnostics (IVD) are laboratory-based analysis performed in in vitro conditions to determine general state of health and presence of diseases, and to assess disease progression and treatment. Infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases are diagnosed in an in vitro environment. Evolution of information technology plays an important role in the development of automated techniques. Increase in geriatric population, rise in disposable income, and high healthcare expenditure in the U.S. drive the market growth. However, unfavorable reimbursement policies and stringent government regulations related to the safety and efficacy of the IVD are expected to restrain the market growth during the forecast period.

  3. Introductionof U.S. IVD Market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits The study provides an in-depth analysis of the U.S. IVD market along with current trends and future estimations to elucidate the imminent investment pockets. Quantitative analysis of the industry is provided for the period of 2016‐2023 to enable the stakeholders to capitalize on the prevailing market opportunities. Comprehensive analysis of factors that drive and restrict the growth of the market is provided. Extensive analysis by technique and application helps understand various trends and prevailing opportunities in the market. The key market players are profiled and their strategies are analyzed to predict the competitive outlook of the market. Click to Access Full Summary of U.S. IVD Market

  5. Table of Content (TOC) Chapter 1: Introduction Chapter 2: Executive Summary Chapter 3: Market Overview Chapter 4: IVD Market, By Product Type Chapter 5: IVD Market, By Technique Chapter: 6 IVD Market, By Application Chapter: 7 IVD Market By End Users Chapter 8: Company Profiles

  6. Segments U.S. IVD Market

  7. Segments U.S. IVD Market

  8. Segments U.S. IVD Market

  9. Company Profiles U.S. IVD Market THERMO FISHER SCIENTIFIC INC. ALERE INC. BIOMERIEUX DANAHER CORPORATION HOFFMANN-LA ROCHE AG BECTON DICKINSON AND COMPANY

  10. Thank You U.S. IVD Market ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/US-IVD-market Follow UsOn

More Related